Search

Your search keyword '"Drosten, Christian"' showing total 2,080 results

Search Constraints

Start Over You searched for: Author "Drosten, Christian" Remove constraint Author: "Drosten, Christian"
2,080 results on '"Drosten, Christian"'

Search Results

2. Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023

3. Divergent Genotype of Hepatitis A Virus in Alpacas, Bolivia, 2019

4. 90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection

5. Four principles to establish a universal virus taxonomy

6. A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity

7. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron

8. Results of German external quality assessment schemes for SARS-CoV-2 antigen detection

9. Omicron subvariant BA.5 efficiently infects lung cells

11. Defining the risk of SARS-CoV-2 variants on immune protection

14. US National Institutes of Health Prioritization of SARS-CoV-2 Variants

15. Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters

19. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

21. Bat species assemblage predicts coronavirus prevalence

23. Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February–December 2021

24. Author Correction: Immunogenetic-pathogen networks shrink in Tome’s spiny rat, a generalist rodent inhabiting disturbed landscapes

25. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays

26. An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution

27. Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant

28. Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies

30. Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19

31. An early warning system for emerging SARS-CoV-2 variants

32. Ineffectiveness of international travel restrictions to contain spread of the SARS-CoV-2 Omicron BA.1 variant: a continent-wide laboratory-based observational study from Africa

33. Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021

35. Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

36. Genetic characterization of varicella-zoster and HIV-1 viruses from the cerebrospinal fluid of a co-infected encephalitic patient, Ghana

38. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta

40. Emergence of SARS-CoV-2 Delta Variant, Benin, May--July 2021

41. Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early 2021

42. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

43. Virus-induced senescence is a driver and therapeutic target in COVID-19

44. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

45. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021

46. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity

47. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

48. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

49. A time-resolved proteomic and prognostic map of COVID-19

Catalog

Books, media, physical & digital resources